Home › Trial NCT02249949
Efatutazone Dihydrochloride in Treating Patients With Previously Treated Myxoid Liposarcoma That Cannot Be Removed by Surgery
- Trial IDNCT02249949
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorAlliance for Clinical Trials in Oncology
- Enrollment15
- Start date2015-02-11
- ConditionsLiposarcoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.